Delivery Order SPE2DB24D2205-SPE2DB25FEGKB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 8, 2025, with a completion date of August 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance of this delivery order will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, operates under firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award to...
- The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery against the contractor's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on July 21, 2025, with an ultimate completion date of August 11, 2025, employs firm fixed pricing under a non-competitive delivery order structure. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a child contract arrangement,...
- The Defense Logistics Agency awarded a delivery order valued at $46,444.95 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order valued at $66,055.04 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGKBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $115,831.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 18, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. This award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. The Varivax vaccine supply supports DLA's ongoing mission to maintain adequate pharmaceutical inventory across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $115.8k | 8/18/25 |